Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Breast 1

Conditions

Breast Neoplasms 55 Neoplasm Metastasis 7 Triple Negative Breast Neoplasms 6 Ovarian Neoplasms 6 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Advanced Breast Cancer 4 Prostatic Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Hereditary Sensory and Autonomic Neuropathies 2 Colorectal Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Solid Tumor 1 Solid Malignancies 1 Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1 Liposarcoma 1 Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1

Interventions

Docetaxel 2 palbociclib 1 nirogacestat 1 Trastuzumab 1 Rogaratinib 1 Fulvestrant 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Cancer Metastatic × Fulvestrant × Clear all

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡